These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 9256028)

  • 1. [Treatment with pilocarpine hydrochloride for sicca symptoms in Sjögren's syndrome].
    Takaya M; Ichikawa Y; Yamada C; Hoshina Y; Horiki T; Uchiyama M
    Ryumachi; 1997 Jun; 37(3):453-7. PubMed ID: 9256028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome.
    Khurshudian AV
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):38-44. PubMed ID: 12539025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca.
    Petrone D; Condemi JJ; Fife R; Gluck O; Cohen S; Dalgin P
    Arthritis Rheum; 2002 Mar; 46(3):748-54. PubMed ID: 11920411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Pilocarpine on impaired salivary secretion in patients with Sjögren's syndrome.
    Jorkjend L; Bergenholtz A; Johansson AK; Johansson A
    Swed Dent J; 2008; 32(2):49-56. PubMed ID: 18700333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candida albicans levels in patients with Sjögren's syndrome before and after long-term use of pilocarpine hydrochloride: a pilot study.
    Rhodus NL; Liljemark W; Bloomquist C; Bereuter J
    Quintessence Int; 1998 Nov; 29(11):705-10. PubMed ID: 10200720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Usefulness of oral pilocarpin therapy in the treatment of xerostomia and xerophthalmia in patients with primary Sjögren's syndrome].
    Solans R; Bosch JA; Selva A; Simeón CP; Fonollosa V; Vilardell M
    Med Clin (Barc); 2004 Feb; 122(7):253-5. PubMed ID: 15012873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study.
    Fox RI; Dixon R; Guarrasi V; Krubel S
    Lupus; 1996 Jun; 5 Suppl 1():S31-6. PubMed ID: 8803908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of sicca symptoms with hydroxychloroquine in patients with Sjogren's syndrome.
    Rihl M; Ulbricht K; Schmidt RE; Witte T
    Rheumatology (Oxford); 2009 Jul; 48(7):796-9. PubMed ID: 19433433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial of bromhexine in Sjögren's syndrome.
    Avisar R; Savir H; Machtey I; Ovaknin L; Shaked P; Menache R; Allalouf D
    Ann Ophthalmol; 1981 Aug; 13(8):971-3. PubMed ID: 7027873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilocarpine and artificial saliva for the treatment of xerostomia and xerophthalmia in Sjögren syndrome: a double-blind randomized controlled trial.
    Cifuentes M; Del Barrio-Díaz P; Vera-Kellet C
    Br J Dermatol; 2018 Nov; 179(5):1056-1061. PubMed ID: 29432648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilocarpine toxicity and the treatment of xerostomia.
    Hendrickson RG; Morocco AP; Greenberg MI
    J Emerg Med; 2004 May; 26(4):429-32. PubMed ID: 15093850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral pilocarpine for symptomatic relief of keratoconjunctivitis sicca in patients with Sjögren's syndrome. The MGI PHARMA Sjögren's Syndrome Study Group.
    Nelson JD; Friedlaender M; Yeatts RP; Yee R; McDermott M; Orlin S; Gallagher SC; Shrotriya RC
    Adv Exp Med Biol; 1998; 438():979-83. PubMed ID: 9634998
    [No Abstract]   [Full Text] [Related]  

  • 13. Sjögren's syndrome: a critical review of clinical management.
    Bell M; Askari A; Bookman A; Frydrych S; Lamont J; McComb J; Muscoplat C; Slomovic A
    J Rheumatol; 1999 Sep; 26(9):2051-61. PubMed ID: 10493692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of orally administered pilocarpine hydrochloride for patients with juvenile-onset Sjögren's syndrome.
    Tomiita M; Takei S; Kuwada N; Nonaka Y; Saito K; Shimojo N; Kohno Y
    Mod Rheumatol; 2010 Oct; 20(5):486-90. PubMed ID: 20517630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of xerostomia in patients with primary Sjögren's syndrome with sulfarlem.
    Schiødt M; Oxholm P; Jacobsen A
    Scand J Rheumatol Suppl; 1986; 61():250-2. PubMed ID: 3473639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of formula ophiopogoins in the treatment of xerostomia and pharyngoxerosis.
    Sugano S; Takeyama I; Ogino S; Kenmochi M; Kaneko T
    Acta Otolaryngol Suppl; 1996; 522():124-9. PubMed ID: 8740826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilocarpine treatment in a mixed cohort of xerostomic patients.
    Aframian DJ; Helcer M; Livni D; Robinson SD; Markitziu A; Nadler C
    Oral Dis; 2007 Jan; 13(1):88-92. PubMed ID: 17241436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oral pilocarpine on post-irradiation xerostomia in head and neck cancer patients: a single-center, single-blind clinical trial.
    Chitapanarux I; Kamnerdsupaphon P; Tharavichitkul E; Sumitsawan Y; Sittitrai P; Pattarasakulchai T; Lorvidhaya V; Sukthomya V; Pukanhaphan N; Traisatit P
    J Med Assoc Thai; 2008 Sep; 91(9):1410-5. PubMed ID: 18843872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cevimeline gargle for the treatment of xerostomia in patients with Sjögren's syndrome.
    Takagi Y; Kimura Y; Nakamura T
    Ann Rheum Dis; 2004 Jun; 63(6):749. PubMed ID: 15140789
    [No Abstract]   [Full Text] [Related]  

  • 20. Conjunctival epithelium improvement after systemic pilocarpine in patients with Sjogren's syndrome.
    Aragona P; Di Pietro R; Spinella R; Mobrici M
    Br J Ophthalmol; 2006 Feb; 90(2):166-70. PubMed ID: 16424527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.